F

Fluoguide AS
STO:FLUO

Watchlist Manager
Fluoguide AS
STO:FLUO
Watchlist
Price: 33.95 SEK -0.88% Market Closed
Market Cap: 462.4m SEK
Have any thoughts about
Fluoguide AS?
Write Note

EV/EBITDA
Enterprise Value to EBITDA

-6.1
Current
-12.8
Median
4.2
Industry
Higher than median
Lower than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA
-6.1
=
Enterprise Value
376.6m SEK
/
EBITDA
-39.8m DKK
All Countries
Close
Market Cap EV/EBITDA
DK
Fluoguide AS
STO:FLUO
421.3m SEK -6.1
FR
Pharnext SCA
OTC:PNEXF
6T USD -219 224.1
US
Abbvie Inc
NYSE:ABBV
314.7B USD 15.4
US
Amgen Inc
NASDAQ:AMGN
147.4B USD 16.5
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
119.4B USD 24.8
US
Gilead Sciences Inc
NASDAQ:GILD
113.8B USD 10
US
Epizyme Inc
F:EPE
94.1B EUR -515.4
AU
CSL Ltd
ASX:CSL
135.4B AUD 20.6
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
82.6B USD 16.2
US
Seagen Inc
F:SGT
39.3B EUR -58.9
NL
argenx SE
XBRU:ARGX
34.3B EUR -104.1
EBITDA Growth
DK
F
Fluoguide AS
STO:FLUO
Average EV/EBITDA: 17.2
Negative Multiple: -6.1
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -219 224.1 N/A
US
Abbvie Inc
NYSE:ABBV
15.4
29%
US
Amgen Inc
NASDAQ:AMGN
16.5
62%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
24.8
43%
US
Gilead Sciences Inc
NASDAQ:GILD
10
16%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -515.4 N/A
AU
CSL Ltd
ASX:CSL
20.6
42%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.2
35%
US
S
Seagen Inc
F:SGT
Negative Multiple: -58.9 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -104.1 N/A

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBITDA
-4.2
2-Years Forward
EV/EBITDA
-2.9
3-Years Forward
EV/EBITDA
5.6

See Also

Discover More